On October 26, Dayang Bio (003017) was listed on the small and medium board. The issuance of 15 million new shares this time, the issue price is 28.85 yuan / share, the net proceeds of about 383 million yuan. After the opening in the morning, the company's stock price has no suspense. As a professional chemical raw material manufacturer, Dayang Bio is mainly engaged in the production and sales of inorganic salts and veterinary raw materials. The company's main products include potassium carbonate, potassium bicarbonate, amproline hydrochloride, and fluorine-containing fine chemicals. Since its establishment, the company has continuously improved its production technology and processes, optimized its production lines, and realized the extension of the industrial chain and the comprehensive utilization of resources. It has now become a leading enterprise in the domestic light potassium carbonate and potassium bicarbonate industries, as well as global amproline hydrochloride (traditional One of the important manufacturers of anticoccidial drugs. The prospectus shows that the company has undertaken and completed more than ten national, provincial and ministerial-level scientific and technological projects, including major national new drug creation projects, the 863 plan, and the national torch plan. The company has obtained many new products and technologies. A provincial and municipal science and technology award. At present, the company has 31 invention patents, 5 utility model patents, and has published more than 30 papers in core academic journals at home and abroad.